Stockreport

Nurix Therapeutics to Participate in Upcoming Investor Conference

Nurix Therapeutics, Inc. - Common stock  (NRIX) 
PDF BRISBANE, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, deve [Read more]